{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:23Z","timestamp":1789990883371,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Muscular Dystrophy Association of America (MDA)"},{"name":"The Association Francaise Contre les Myopathies (AFM)"},{"DOI":"10.13039\/501100000780","name":"The European Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eurothymaide"},{"DOI":"10.13039\/501100000589","name":"The Chief Scientist Office","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Israel Ministry of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jaut.2015.09.005","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T04:54:59Z","timestamp":1445576099000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells"],"prefix":"10.1016","volume":"67","author":[{"given":"Revital","family":"Aricha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debby","family":"Reuveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C.","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2015.09.005_bib1","doi-asserted-by":"crossref","first-page":"972865","DOI":"10.1155\/2013\/972865","article-title":"Dendritic cells: cellular mediators for immunological tolerance","volume":"2013","author":"Chung","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00018-009-0026-2","article-title":"The development and function of regulatory T cells","volume":"66","author":"Workman","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jaut.2015.09.005_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaut.2015.09.005_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.gastro.2010.06.006","article-title":"Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy","volume":"139","author":"Moes","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.09.005_bib8","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.09.005_bib10","first-page":"11","article-title":"Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis","volume":"19","author":"Abramsky","year":"1975","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib11","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1073\/pnas.87.19.7792","article-title":"Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis","volume":"87","author":"Protti","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2015.09.005_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.50.4.1045","article-title":"T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis","volume":"50","author":"Wang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2015.09.005_bib13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1212\/WNL.36.5.618","article-title":"Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines","volume":"36","author":"Hohlfeld","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2015.09.005_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2014.06.003","article-title":"Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches","volume":"54","author":"Fuchs","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.09.005_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/08916930903518081","article-title":"Development of novel therapies for MG: studies in animal models","volume":"43","author":"Souroujon","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2015.09.005_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2015.09.005_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2015.09.005_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.09.005_bib19","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"Mu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.09.005_bib20","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex\u00a0vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0019-2791(77)90291-9","article-title":"Immunochemical studies on acetylcholine receptor from Torpedo californica","volume":"14","author":"Aharonov","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.jaut.2015.09.005_bib22","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2004.04.010","article-title":"Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment","volume":"152","author":"Maiti","year":"2004","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2015.09.005_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaut.2010.06.017","article-title":"The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies","volume":"35","author":"Tsuda","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.09.005_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2015.09.005_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.09.005_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: take a billion or so and call me in the morning","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.09.005_bib29","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.4049\/jimmunol.181.12.8209","article-title":"Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease","volume":"181","author":"Huter","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib30","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/art.34513","article-title":"Antigen-specific TGF-\u03b2-induced regulatory T cells but not natural Tregs ameliorate autoimmune arthritis by shifting the balance of Th17 toward Treg cells","volume":"64","author":"Kong","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2015.09.005_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaut.2015.09.005_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2015.09.005_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","article-title":"Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?","volume":"4","author":"Lan","year":"2012","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2015.09.005_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib35","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/eji.201141503","article-title":"Polyclonal Treg cells modulate T effector cell trafficking","volume":"41","author":"Davidson","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib36","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.4049\/jimmunol.1000423","article-title":"Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection","volume":"185","author":"Fulton","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.09.005_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/icb.2010.76","article-title":"Polyclonal Treg cells enhance the activity of a mucosal adjuvant","volume":"88","author":"Vendetti","year":"2010","journal-title":"Immunol. Cell Biol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:12:47Z","timestamp":1760256767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841115300445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":37,"alternative-id":["S0896841115300445"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2015.09.005","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}